Search Within

Kai Dannebom Rejeski

Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
  3. Review (7)
  4. Editorial (2)
  5. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (22)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Bone Marrow Transplant (15)
  5. GME, Medicine (15)
  6. Graduate Medical Education (15)

More Groups

People
  1. Roni Shouval (20)
  2. Miguel-Angel Perales (15)
  3. Gilles Salles (11)
  4. Jae Park (11)
  5. Maria Palomba (10)
  6. Gunjan Shah (9)

More People

Years
  1. 2025 (15)
  2. 2024 (20)
Publications
  1. Blood (11)
  2. Blood Advances (3)
  3. Bone Marrow Transplantation (3)
  4. Blood Cancer Journal (2)
  5. HemaSphere (2)
  6. Nature Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (2)
  5. Elsevier Science, Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Development of ALL-Hematotox: Predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
    Journal Article

    Nair, M. S.; Silbert, S. K.; Rejeski, K.; Wilson, K. A.; Lamble, A. J.; Valtis, Y.; Yates, B.; Morales Arana, A.; Shouval, R.; Curran, K.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Dynamics of immune reconstitution and impact on outcomes across CAR-T cell products in large B-cell lymphoma
    Journal Article

    Luan, D.; DeWolf, S.; Fei, T.; Raj, S.; Shah, G. L.; Lareau, C. A.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma
    Journal Article

    Stock, S.; Bücklein, V. L.; Blumenberg, V.; Magno, G.; Emhardt, A. J.; Holzem, A. M. E.; Cordas dos Santos, D. M.; Schmidt, C.; Grießhammer, S.; Frölich, L.; more...
    HemaSphere (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Predictive value of maximum tumor dissemination (Dmax) in lymphoma patients treated with CDI9 specific CAR T-cell therapy
    Meeting Abstract

    Kunz, W. G.; Blumenberg, V.; Rejeski, K.; Sheik, G.; Brendel, M.; Von Bergwelt, M.; Subklewe, M.; Winkelmann, M.
    Blood (2024)

    Fulltext@MSK | Save
  • Global access to chimeric antigen receptor (CAR) T-cell therapies: Health technology assessment (HTA) of CAR T in G7 countries and Australia
    Meeting Abstract

    Ge, A. Y.; Feldman, W. B.; Kaiser, M. F.; Rejeski, K.; Iacoboni, G.; Dickinson, M. J.; Kesselheim, A. S.; Cliff, E. R. S.
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Inflammation-based scores predict survival after CD3xCD20 bispecific T cell engagers in R/R LBCL
    Meeting Abstract

    Magno, G.; Rejeski, K.; Rappa, G.; Kupf, S.; Stock, S.; Holzem, A. M. E.; Scholz, J. K.; Wurm-Kuczera, R.; Harlev, S.; Kutsch, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rejeski, K.; Hansen, D. K.; Cordas Dos Santos, D. M.; De Menezes Silva Corraes, A.; Castaneda, O.; Dillard, C. M.; Alsdorf, W.; Frenking, J. H.; Purcarea, A.; Chhabra, S.; more...
    Blood (2024)

    Fulltext@MSK | Save